# Colchicine Use in Intracranial Atherosclerotic Disease

> **NCT05503225** · PHASE2 · RECRUITING · sponsor: **Chinese University of Hong Kong** · enrollment: 72 (estimated)

## Conditions studied

- ICAD - Intracranial Atherosclerotic Disease

## Interventions

- **DRUG:** Colchicine 0.5 MG

## Key facts

- **NCT ID:** NCT05503225
- **Lead sponsor:** Chinese University of Hong Kong
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2022-11-28
- **Primary completion:** 2025-09-30
- **Final completion:** 2026-05-31
- **Target enrollment:** 72 (ESTIMATED)
- **Last updated:** 2024-09-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05503225

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05503225, "Colchicine Use in Intracranial Atherosclerotic Disease". Retrieved via AI Analytics 2026-07-11 from https://api.ai-analytics.org/clinical/NCT05503225. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*